Peer mentorship to reduce suicide risk following psychiatric hospitalization

同伴辅导可降低精神病住院后的自杀风险

基本信息

项目摘要

DESCRIPTION (provided by applicant): Suicide is a leading cause of death and suicide attempts are a major cause of disability, lost productivity, and health care costs. Suicide prevention is a research priority of the National Institutes of Health, and the US Surgeon General's National Strategy for Suicide Prevention calls for a shift towards recovery-oriented prevention efforts which promote hope and social support. Hopelessness and social isolation are two proximal risk factors for suicide which may be improved via peer mentorship, a form of peer support effective for preventing depression and repeat psychiatric hospitalizations. The primary aims of this study are to develop and pilot test a peer mentorship intervention for psychiatrically hospitalized patients at high risk for suicide. The intervention will be adapted by an expert panel from existing peer support training protocols to target suicide risk factors and to enhance suicide risk management. Protocols for training and supervising peer mentors and measures of intervention fidelity will also be developed. The intervention will then be pilot teste among 60 participants randomly assigned to receive the peer mentorship intervention plus usual care or usual care alone. Participants will be recruited from the inpatient psychiatry unit at the University of Michigan Health System. Inclusion criteria will include medical record documentation of suicidal ideation or suicide attempt at admission, and exclusion criteria will include significant cognitive impairment (according to the Mini-Cog), current receipt of peer support, or determination that peer mentorship may cause distress to the patient or the peer mentor. The peer mentorship intervention will include an in-person visit on the inpatient unit and regular in-person or telephone follow-up for 3 months post-discharge. The intervention will be delivered by peer specialists--individuals in stable recovery from serious mental illness who have received formal training and certification in peer support from the state of Michigan--with at least 6 months of professional peer support experience. The primary outcomes of the pilot study are acceptability and feasibility of the intervention as determined by: 1) >50% of eligible participants enroll in the study, 2) >70% of enrollees complete final follow- up measures at 6 months, and 3) among those assigned to the peer mentorship intervention, >80% complete an inpatient session and the median number of total sessions is at least 4. Peer mentorship sessions will be recorded and rated for fidelity. Measures of suicidal ideation and suicide attempts (the intended primary outcomes of a subsequent efficacy study) and secondary outcomes such as quality of life, functioning, depression, and service use will be obtained at baseline, 3 months, and 6 months post-enrollment by a research assistant blinded to study arm. An exploratory aim will be to measure potential mediators of intervention effectiveness including belongingness, burdensomeness, and hopelessness according to the interpersonal theory of suicide. If acceptability and feasibility are demonstrated, the study will result in a novel recovey-oriented suicide prevention intervention ready for a fully-powered randomized controlled efficacy trial.
描述(由申请人提供):自杀是死亡的主要原因,自杀企图是残疾,生产力失去和医疗保健费用的主要原因。预防自杀是美国国立卫生研究院的研究优先事项,美国外科医生的自杀预防战略要求转向以恢复为导向的预防努力,以促进希望和社会支持。绝望和社会隔离是自杀的两个近端风险因素,可以通过同伴指导改善,这是一种有效预防抑郁和重复精神病住院的同伴支持形式。这项研究的主要目的是开发和试点测试自杀危险的精神病患者的同伴指导干预。干预将由 来自现有同行支持培训方案的专家小组,以针对自杀风险因素和 增强自杀风险管理。还将制定用于培训和监督同伴导师的协议以及干预忠诚度的措施。然后,干预将是60名随机分配的参与者中的试点测试,以接受同伴指导干预以及通常的护理或通常的护理。参与者将从密歇根大学卫生系统的住院精神病学部门招募。纳入标准将包括自杀念头或自杀尝试的病历记录文件,排除标准将包括重大认知障碍(根据迷你案例),当前的同伴支持或同伴指导可能会给患者或同伴导师带来困扰的确定。同行指导干预将包括对住院单位进行面对面的访问,并在入院后3个月进行定期面对面或电话随访。这项干预将由同伴专家(从严重的精神疾病中恢复稳定的恢复的个人)进行 至少有6个月的专业同伴支持经验。试验研究的主要结果是由以下方式确定的干预措施的可接受性和可行性:1)> 50%的符合条件的参与者参加了研究,2)> 70%> 70%> 70%的参与者完成最终措施,在6个月时完成最终措施,而3)在分配给同伴的指导措施中,> 80%的录制率> 80%的录制率> 80%的录制率至少是一项不错的选择。并评为忠诚。自杀念头和自杀尝试(随后的疗效研究的预期主要结果)和次要结果(例如生活质量,功能,抑郁和服务使用质量)将在基线,3个月和6个月后由研究助手蒙蔽,以实现研究助手。一个探索性的目的是根据人际自杀理论来衡量干预有效性的潜在调解人,包括归属感,负担和绝望。如果证明了可接受性和可行性,则该研究将导致一项新的面向回收的自杀预防干预措施,准备进行全功率的随机控制疗效试验。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul Nelson Pfeiffer其他文献

Paul Nelson Pfeiffer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul Nelson Pfeiffer', 18)}}的其他基金

Development and Pilot Study of Primary Care Loneliness Interventions to Prevent Suicide
预防自杀的初级保健孤独干预措施的开发和试点研究
  • 批准号:
    10646959
  • 财政年份:
    2023
  • 资助金额:
    $ 31.01万
  • 项目类别:
Effectiveness and Implementation of a Peer Mentorship Intervention (PREVAIL) to Reduce Suicide Attempts Among High-Risk Adults
同伴辅导干预 (PREVAIL) 减少高危成年人自杀企图的有效性和实施
  • 批准号:
    10379598
  • 财政年份:
    2021
  • 资助金额:
    $ 31.01万
  • 项目类别:
Incorporating Treatment Outcomes into Quality Measurement of Depression Care
将治疗结果纳入抑郁症护理的质量衡量
  • 批准号:
    9789661
  • 财政年份:
    2016
  • 资助金额:
    $ 31.01万
  • 项目类别:
Incorporating Treatment Outcomes into Quality Measurement of Depression Care
将治疗结果纳入抑郁症护理的质量衡量
  • 批准号:
    10152358
  • 财政年份:
    2016
  • 资助金额:
    $ 31.01万
  • 项目类别:
Peer mentorship to reduce suicide risk following psychiatric hospitalization
同伴辅导可降低精神病住院后的自杀风险
  • 批准号:
    8678081
  • 财政年份:
    2014
  • 资助金额:
    $ 31.01万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
  • 批准号:
    10748859
  • 财政年份:
    2024
  • 资助金额:
    $ 31.01万
  • 项目类别:
Traumatic Brain Injury Anti-Seizure Prophylaxis in the Medicare Program
医疗保险计划中的创伤性脑损伤抗癫痫预防
  • 批准号:
    10715238
  • 财政年份:
    2023
  • 资助金额:
    $ 31.01万
  • 项目类别:
Impact of Autonomic Dysfunction on Multi-Organ Dysfunction following Severe TBI: The AUTO-BOOST Study
严重 TBI 后自主神经功能障碍对多器官功能障碍的影响:AUTO-BOOST 研究
  • 批准号:
    10607731
  • 财政年份:
    2023
  • 资助金额:
    $ 31.01万
  • 项目类别:
Elucidating the role of type I interferon signaling and macrophage-derived inflammation in the juvenile host with viral pneumonia
阐明 I 型干扰素信号传导和巨噬细胞衍生炎症在病毒性肺炎幼年宿主中的作用
  • 批准号:
    10651426
  • 财政年份:
    2023
  • 资助金额:
    $ 31.01万
  • 项目类别:
Improving Healthcare Quality and Equity For Older Adults with HIV Under Value-Based Care Models
在基于价值的护理模式下提高艾滋病毒感染者的医疗质量和公平性
  • 批准号:
    10762522
  • 财政年份:
    2023
  • 资助金额:
    $ 31.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了